Heat Biologics to Present at Biotech Showcase 2017 Conference in San Francisco
Jan 05, 2017 13:01 pm UTC| Business
DURHAM, N.C., Jan. 05, 2017 -- Heat Biologics, Inc. (“Heat”) (Nasdaq:HTBX), a leader in the development of immunotherapies designed to activate a patient’s immune system against cancer, announced that Jeff Wolf, Heat’s...
Jan 05, 2017 13:00 pm UTC| Business
NEWARK, Calif., Jan. 05, 2017 -- CymaBay Therapeutics, Inc. (NASDAQ:CBAY), a clinical-stage biopharmaceutical company developing therapies to treat specialty and orphan diseases with high unmet medical need, today...
Jan 05, 2017 13:00 pm UTC| Business
EXTON, Pa., Jan. 05, 2017 -- Fibrocell Science, Inc. (NASDAQ:FCSC), a gene therapy company focused on transformational autologous cell-based therapies for skin and connective tissue diseases, today announced that the U....
Jan 05, 2017 13:00 pm UTC| Business
SAN DIEGO, Jan. 05, 2017 -- Fate Therapeutics, Inc. (NASDAQ:FATE), a biopharmaceutical company dedicated to the development of programmed cellular immunotherapies for cancer and immune disorders, announced today that...
Infinera Xceed Software Suite Powered by OpenDaylight
Jan 05, 2017 13:00 pm UTC| Business
SUNNYVALE, Calif., Jan. 05, 2017 -- Infinera, a provider of Intelligent Transport Networks, announced that the Infinera Xceed Software Suite (Xceed) is the first optical transport software-defined networking (SDN)...
Jan 05, 2017 13:00 pm UTC| Business
EFFINGHAM, Ill., Jan. 05, 2017 -- Midland States Bancorp, Inc. (NASDAQ:MSBI) announced today that it will issue its fourth quarter 2016 financial results after market close on Thursday, January 26, 2017. Midland...
Jan 05, 2017 13:00 pm UTC| Business
PARIS and BOSTON, Jan. 05, 2017 -- Neovacs (Alternext Paris:ALNEV) a leader in active immunotherapies for the treatment of autoimmune diseases, today announced its collaboration with Professor Robert Kerbel and his team...